Nearly 300 people gathered Tuesday to mark the ceremonial groundbreaking for Biogen’s new state-of-the-art facility in Kendall Square. The project is the first building to be constructed at MIT’s Kendall Common on the former Volpe federal site, and will serve as a consolidated headquarters for the pioneering biotechnology company which has called Cambridge home for more than 40 years.
Biogen’s March 2025 announcement that it will centralize operations at 75 Broadway was lauded as a show of strength for the historic company and the life sciences sector. The 580,000-square-foot research and development headquarters, designed by Elkus Manfredi Architects, will optimize Biogen’s scientific discovery and clinical processes. The new facility is scheduled to open in 2028.
Threaded Mode